A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors

NCT00057473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: carboplatin + irinotecan
DRUG: irinotecan

Sponsor

Bristol-Myers Squibb